Journals / Turkish Journal of Pediatrics / 2018 / Cilt: 60 - Sayı: 3

A case of myeloid sarcoma presenting with an orbital mass, hearing loss, and multiple cranial neuropathies

Pages
322–325
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case alerts us that in patients with diverse sarcomatouslesions, acute myeloid leukemia presenting as myeloid sarcoma should beconsidered.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Primary myeloid sarcoma occurring in multiple sites; orbit, ear, brain, andspinal cord is a rare clinical entity.
📊
Key Findings & Data:A 15-year-old male adolescent presentedwith bilateral orbital mass, hearing difficulty, and clinical signs of multiplecranial nerves palsy.
💡
Conclusion & Impact:This case alerts us that in patients with diverse sarcomatouslesions, acute myeloid leukemia presenting as myeloid sarcoma should beconsidered.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Primary myeloid sarcoma occurring in multiple sites; orbit, ear, brain, andspinal cord is a rare clinical entity. A 15-year-old male adolescent presentedwith bilateral orbital mass, hearing difficulty, and clinical signs of multiplecranial nerves palsy. Approximately 6 weeks later, acute myeloid leukemiawas confirmed. This case alerts us that in patients with diverse sarcomatouslesions, acute myeloid leukemia presenting as myeloid sarcoma should beconsidered.

🔖

Cite This Article

LIM, S., NAM, H., LIM, K., JEON, I. (2018). A case of myeloid sarcoma presenting with an orbital mass, hearing loss, and multiple cranial neuropathies. Turkish Journal of Pediatrics, Cilt: 60 - Sayı: 3, 322–325. https://ajindex.com/articles/412116

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA. Trends in leukemia incidence and survival in the United States (1973-1998). Cancer 2003; 97: 2229-2235
  2. Dusenbery KE, Howells WB, Arthur DC, et al. Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: A report from the Children's Cancer Group. J Pediatr Hematol Oncol 2003; 25: 760-768
  3. Peterson LF, Zhang DE. The 8;21 translocation in leukemogenesis. Oncogene 2004; 23: 4255-4262 4. Campidelli C, Agostinelli C, Stitson R, Pileri SA. Myeloid sarcoma: Extramedullary manifestation of myeloid disorders. Am J Clin Pathol 2009; 132: 426- 437
  4. Seifert RP, Bulkeley III W, Zhang L, Menes M, Bui MM. A practical approach to diagnose soft tissue myeloid sarcoma preceding or coinciding with acute myeloid leukemia. Ann Diagn Pathol 2014; 18: 253-260
  5. Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases. Cancer 1981; 48: 1426-1437
  6. Klco JM, Welch JS, Nguyen TT, et al. State of the art in myeloid sarcoma. Int J Lab Hematol 2011; 33: 555-565
  7. Chang KH, Kim DK, Jun BC, Park YS. Temporal bone myeloid sarcoma. Clin Exp Otorhinolaryngol 2009; 2: 198-202
  8. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer 2002; 94: 1739-1746
  9. Yilmaz AF, Saydam G, Sahin F, Baran Y. Granulocytic sarcoma: a systematic review. Am J Blood Res 2013; 3: 265-270
  10. Antic D, Elezovic I, Milic N, et al. Is there a "gold" standard treatment for patients with isolated myeloid sarcoma? Biomed Pharmacother 2013; 67: 72-77
  11. Paydas S, Zorludemir S, Ergin M. Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 2006; 47: 2527-2541
  12. Park KU, Lee DS, Lee HS, Kim CJ, Cho HI. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement. Am J Pathol 2001; 159: 2011- 2016
  13. Chang M, Raimondi SC, Ravindranath Y, et al. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821. Leukemia 2000; 14: 1201-1207.